Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease (Q39220366)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease |
scientific article |
Statements
1 reference
Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease (English)
1 reference
Yi-Ju Pan
1 reference
Kuei-Hong Kuo
1 reference
Hung-Yu Chan
1 reference
16 March 2014
1 reference
1 reference
54
1 reference
70-78
1 reference
Identifiers
1 reference
1 reference